HZ84ZZZ
Medication Management Naltrexone to None with None, None Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | H Substance Abuse Treatment |
| Body System | Z None |
| Operation | 8 Medication Management |
| Body Part | 4 Naltrexone |
| Approach | Z None |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Monitoring and adjusting the use of replacement medications for the treatment of addiction
Procedure Overview
Medication management in substance abuse treatment refers to the ongoing clinical oversight of medications used to treat addiction, most often replacement therapies such as methadone or buprenorphine for opioid use disorder. Rather than administering a new dose, this service centers on a prescriber or care team reviewing how a patient is responding to their current regimen and making adjustments as needed. It is a recurring, supervisory activity that continues for as long as the patient remains on medication-assisted treatment.
During a medication management visit, a physician, nurse practitioner, or physician assistant evaluates the patient for signs of withdrawal, cravings, side effects, or misuse, and may increase, decrease, or otherwise modify the dose based on that assessment. This oversight is a cornerstone of medication-assisted treatment programs because replacement medications carry their own risks, including diversion and overdose, and require careful titration over time. The visits also give clinicians an opportunity to monitor for co-occurring mental health conditions and coordinate with counseling services the patient may be receiving concurrently.
Anatomy & Axis Detail
Naltrexone
Naltrexone is an opioid receptor antagonist used in two distinct substance abuse contexts, blocking the rewarding effects of opioids in patients recovering from opioid use disorder and reducing the reinforcing effects of alcohol in those being treated for alcohol use disorder. It is available as a daily oral tablet or as a monthly extended-release intramuscular injection, and the route chosen affects both adherence and how the encounter is documented. Because naltrexone will precipitate acute withdrawal in anyone with opioids still in their system, management requires confirming a sufficient opioid-free interval, often seven to ten days, before initiating therapy. Coders should note whether the visit represents initiation, an injection encounter, or ongoing oral maintenance, since these carry different clinical and administrative implications.
Coding & Documentation
This code applies when the documentation shows a clinician reviewing and adjusting an existing medication regimen for addiction treatment, such as changing a buprenorphine dose after evaluating the patient's response. The note should reflect clinical decision-making about the medication itself, not simply that a dose was administered. A frequent coding error is applying this instead of Pharmacotherapy when the encounter actually involved starting or continuing a medication without any monitoring or dose adjustment documented, or applying it when the visit was purely a counseling session that happened to mention medication in passing.
Commonly Confused With
The closest point of confusion is with Pharmacotherapy, also in this section. Pharmacotherapy captures the act of administering the replacement medication itself, while Medication Management captures the evaluation and adjustment of that regimen over time; a single encounter can sometimes involve both, but each needs its own supporting documentation. It can also be confused with routine medication administration coded elsewhere in ICD-10-PCS when the substance being given is not part of an addiction treatment protocol.